To test the hypothesis that single-nucleotide polymorphisms (SNPs) in Toll-like receptor (TLR) genes alter susceptibility to bacterial infections and modulate white blood cell (WBC) counts during infections in very low birth weight (VLBW) infants (birth weight o1500 g). STUDY DESIGN: VLBW infants recruited in a multicenter study were genotyped for nine functional TLR SNPs and associations between SNPs and infection rates examined. WBC counts obtained during infections were compared among infants with and without SNPs. RESULT: In our cohort (n ¼ 408), 90 infants developed bacterial infections. Presence of TLR4 (rs4986790 and rs4986791) variants were associated with Gram-negative (G-ve) infections. Female infants heterozygous for the X-linked IRAK1 (rs1059703) SNP had less G-ve infections. In regression models controlling for confounders, the TLR4 (rs4986790) SNP was associated with increased G-ve infections. The TLR5 (rs5744105) variant was associated with elevated WBC counts during infections. CONCLUSION: TLR genetic variants can contribute to increased risk of bacterial infections and altered immune responses in VLBW infants.
INTRODUCTION
Bacterial infections remain a major cause of morbidity and mortality in very low birth weight (VLBW) infants.
1,2 Perinatal factors such as clinical chorioamnionitis, maternal group B streptococcus status, duration of rupture of membranes as well as infant characteristics such as gestational age, birth weight, use of indwelling vascular catheters and ventilation are known risk factors for bacterial infections in this population. [1] [2] [3] Although recent evidence suggests that genetic factors contribute significantly to diseases in VLBW infants, genetic loci that increase susceptibility to infections have not yet been characterized. [4] [5] [6] The pathogenesis of infections in humans is complex, but can arise from a failure of host genome-regulated mucosal immune defenses to overcome invasive pathogens. 7 The VLBW infant's ability to fight infections is compromised as neutrophil function is inadequate, humoral and T-cell responses are ontogenically restricted and transplacental transfer of immunoglobulin is incomplete. 8, 9 In this setting, intact functioning of the innate immune system is critical to prevent bacterial diseases. We hypothesized that aberrant functioning of the innate immune system arising from functional genetic variation in pathogen recognition receptors will increase the risk of infections in VLBW infants.
The Toll-like receptor (TLR) signaling pathway proteins are pattern recognition receptors that recognize signature microbial motifs and stress ligands. 10 TLR-mediated innate immune responses have an important role in preventing bacterial invasion, maintaining mucosal homeostasis and regulating inflammation. 10, 11 Studies in adults and children demonstrate that TLR genetic variants modulate susceptibility to sepsis, pneumococcal infections and other infections with increased penetrance in childhood. 7, 12, 13 In this study, we investigated the impact of nine functional TLR singlenucleotide polymorphisms (SNPs) on bacterial infections in a VLBW infant cohort. Recognition of pathogens by TLRs results in expression of chemokines and cytokines such as C5a, interleukin-8 and granulocyte-macrophage colony-stimulating factor, which regulate the release and activation of immune cells (neutrophils and monocytes) from the bone marrow. 14, 15 Infections in VLBW infants are often characterized by changes in the white blood cell (WBC) and absolute neutrophil count (ANC), and WBC indices are used to screen for sepsis in this population. 16, 17 As the TLRs regulate the immune response to microbes, we also examined whether WBC/ ANC counts obtained during infection episodes are regulated by TLR genotype.
METHODS

Patient recruitment
VLBW infants were recruited prospectively from tertiary neonatal intensive care units at Children's Hospital of Wisconsin (Milwaukee, WI, USA), St Joseph's Hospital (Milwaukee, WI, USA), Kosair's Children's Hospital (Louisville, KY, USA), Rush University Medical Center (Chicago, IL, USA) and Children's Hospitals and Clinics of Minnesota (Minneapolis, MN, USA) between October 2006 and January 2012 after institutional review board approval at each center. After consent was obtained, 0.5 ml of blood was collected in de-identified sample containers, labeled with the study ID number and shipped on ice to Children's Hospital of Wisconsin where DNA extraction and genotyping was done. Epidemiological data and disease outcomes recorded in a standardized data sheet were extracted and entered into a password-protected database.
Eligibility
Preterm infants with a birth weightp1500 g (VLBW) admitted to the participating neonatal intensive care units were eligible if they did not have chromosomal disorders or major congenital anomalies.
Definition of cases
Infants with clinical signs of sepsis were considered to have a culturepositive (C þ ve) infection if bacteria or Candida spp. were isolated from blood, trachea, urine or cerebrospinal fluid and they were treated with antibiotics forX5 days. Tracheal infections were defined in the presence of a positive tracheal aspirate culture when there was radiographic evidence of pneumonia and/or when there was a change in the infant's clinical status.
Selection of SNPs
TLR pathway genes essential for mediating immune responses against known bacterial and fungal pathogens in this population were targeted. SNPs in candidate genes were identified by searching databases such as PubMed and dBSNP and selected based on: (a) whether they were reported to modulate infectious disease susceptibility, (b) demonstration of altered functionality with the variant and (c) mean allele frequency of 42% among Caucasians.
Genotyping
DNA was extracted from blood samples using the FlexiGene DNA kit (Qiagen, Valencia, CA, USA). The nine TLR pathway SNPs (TLR2 (rs5743708), TLR4 (rs4986790 and rs4986791), TLR5 (rs5744168), TLR9 (rs352140), IRAK1 (rs1059703), TIRAP (rs8177374), NFKB1 (28362491) and NFKBIA (rs3138053)) were genotyped by developing a multiplexed single-base extension assay using the ABI PRISM SNaPshot Multiplex kit (Applied Biosystems, Foster City, CA, USA) and performed essentially as described before. 6 
Quality control
Seven percent of samples were re-genotyped by a technician blinded to prior results. There was 100% concordance for all samples.
Estimation of WBC/ANC counts WBC counts acquired when blood, urine, cerebrospinal fluid or tracheal cultures were obtained were used. WBC counts were quantified using automated cell analyzers such as Cell-Dyn Sapphire (Abbott Diagnostics, Santa Clara, CA, USA) and Beckman-Coulter (Brea, CA, USA). ANC was calculated based on the proportion of neutrophils in the differential WBC count.
Statistical analysis
Categorical demographic variables were analyzed using w 2 tests. WilcoxonMann-Whitney rank sum test was used for continuous variables like birth weight and central venous line (CVL) days.
Power and sample size A genetic dominance model was used for power calculations. Assuming a rate of 24% for C þ ve infections, a sample size of 400 would give us 80% power to detect a 12 to 15% difference in the prevalence of SNPs between infants with and without infections assuming a Po0.05. Rates of C þ ve, Gram-positive (G þ ve), and Gram-negative (G-ve) infections were compared among infants with and without TLR SNPs using w 2 tests or Fisher's exact test. Bonferroni correction was applied to adjust for multiple comparisons (nine SNPs). To control for potential confounders, we developed temporal logistic regression models in which risk factors present at birth (birth weight, race, antenatal steroids, gender, chorioamnionitis, gestational age, sex, Apgar-5 min and so on) along with TLR SNPs were examined for association with infections. Nonsignificant variables (Po0.10) were removed in a stepwise manner until only those associated (Po0.05) with a phenotype remained. CVL days was then added to the model and stepwise elimination done to identify variables significantly associated with each infection phenotype. WBC and ANC counts obtained during the first episode of C þ ve infection were compared between VLBW infants with TLR variants and those without using Wilcoxon-Mann-Whitney rank sum test. Linear regression was used to explore inter-relationships between genetic variants, epidemiological variables and WBC counts. SPSS 19.0 (SPSS, Chicago, IL, USA) and SAS 9.3 (SAS, Cary, NC, USA) were used for data analysis.
RESULTS
Infections in VLBW cohort
In our cohort (n ¼ 408), 90 infants developed C þ ve infections. Forty infants had blood stream infections, 13 had blood and tracheal infections, 4 had blood and urinary tract infections, 26 had tracheal infections, 3 developed urinary tract infections and 4 had tracheal and urinary tract infections. Early-onset infection (p3 days) was detected in 3.4% (14/408) of infants while late-onset infections (43 days) occurred in 19.8% (81/408). There were 129 C þ ve infection episodes with 25 infants (5.6%) having two or more episodes. Bacteria isolated during C þ ve infections are shown in the supplement section (Supplementary Table 1 ). Infants with infections had a lower birth weight, were more premature and required more CVL days when compared with infants without infections ( Table 1) . Comparisons between infants with G-ve or G þ ve infections and infants without infections showed similar results as above (data not shown).
TLR pathway variants and infection outcomes in VLBW cohort
Hardy-Weinberg equilibrium was confirmed for all SNPs except for the IRAK-1 variant, which is X-linked. The NFKB1, NFKBIA, TIRAP, TLR2, TLR5 and TLR9 SNPs were not associated with infection phenotypes (Table 2) . Functional studies have shown that presence of both TLR4 variants disrupts signaling more profoundly than either variant. 18 Presence of both TLR4 SNPs was associated with C þ ve infections (odds ratio (OR) ¼ 2.32, 95% confidence interval (CI): 1.02 to 5.25, P ¼ 0.026) while presence of the TLR4 -3 or fetal heart rate of 4160 per min). *Po0.001,
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(rs4986790) SNP alone showed a marginal (P ¼ 0.06) association with increased infections (Figure 1 ). As TLR4 recognizes lipopolysaccharide (LPS) from G-ve bacteria we examined associations between TLR4 SNPs and G-ve infections (Figure 1) . Infants who had both TLR4 variants had increased G-ve infections (OR ¼ 3.7, 95% CI: 1.4 to 9.6, P ¼ 0.002). Presence of the TLR4 (rs4986790) variant alone was associated with increased G-ve infections (OR ¼ 3.2, 95% CI: 1.3 to 7.5, P ¼ 0.003). The above associations met the Bonferroni statistic of Po0.0055.
As studies in adults have reported gender-dependent effects of the X-linked IRAK1 SNP (rs1059703) on inflammation, 19 we examined the gender-dependent effects of this variant on infection outcomes. In our cohort, there was a trend toward decreased G-ve infections in females (male vs female; 25/212 vs 14/196, P ¼ 0.10). Female infants with the C/T genotype had decreased rates of G-ve infections (Figure 2 ) when compared with other infants (male or female) who were T/T or C/C at the variant 
TLR4 SNPs are associated with G-ve infections
In regression models that adjusted for potential confounders, only birth weight (Po0.001) and CVL days (P ¼ 0.001) were associated with C þ ve or G þ ve infection. In models that examined risk factors for G-ve infections, we noted that the TLR4 (rs4986790) variant, birth weight and CVL days were associated with increased G-ve infections while presence of the T/C genotype at the variant IRAK1 locus had a protective effect (Table 3) . Among Caucasian infants (n ¼ 285), the largest racial group, 65 (23%) developed C þ ve infections (44 G þ ve and 28 G-ve). Both TLR4 variants were inherited together and in complete linkage disequilibrium. Infants with TLR4 SNPs had increased G-ve infections (8/30 vs 20/254; OR ¼ 4.3, 95% CI: 1.5 to 11.7, P ¼ 0.004) but not G þ ve infections.
TLR variants and risk of blood stream or urinary tract infection
We examined the relationship between TLR SNPs and infections excluding infants with tracheal infection. In this group (n ¼ 64), 39 infants had G þ ve infection and 27 developed G-ve infection. TLR SNPs were not associated with increased C þ ve or G þ ve infection except for a trend toward more C þ ve infection with presence of both TLR4 SNPs (P ¼ 0.07). Presence of the TLR4 (rs4986790) SNP (OR ¼ 3.3, 95% CI: 1.3 to 8.4, P ¼ 0.008) or presence of both TLR4 SNPs (OR ¼ 4.6, 95% CI: 1.6 to 12.6, P ¼ 0.002) was associated with increased G-ve but not G þ ve infections (Figure 3) . In regression models for G-ve infection, only birth weight (Po0.001), CVL days (Po0.001) and the TLR4 (rs4986790) variant (P ¼ 0.04) were associated with increased blood stream or urinary tract infection.
TLR SNPs and WBC counts WBC and ANC counts obtained during the first episode of C þ ve infection in 90 infants who had infections were compared among infants with and without TLR SNPs (Supplementary Table 2 ). Infants with the TLR5 SNP (rs5744168) had higher WBC (P ¼ 0.02) and ANC counts (P ¼ 0.08) during C þ ve infection. Linear regression models exploring associations between clinical variables (such as sex, race, and so on) and TLR variants showed that the TLR5 SNP modified the relationship between birth weight and WBC count (Figure 4) . In infants without the TLR5 variant, there was no correlation between birth weight and WBC counts while in infants with the TLR5 SNP, an increasing birth weight was associated with higher WBC count (P ¼ 0.01).
DISCUSSION
Although complete loss-of-function mutations in TLR pathway genes such as IRAK4 are a cause of primary immunodeficiency, the role of TLR signaling pathway SNPs in altering susceptibility to infections in the VLBW infant population remains understudied. 13 In this study, we report a novel association between presence of non-synonymous TLR4 variants and increased G-ve infection in VLBW infants. Our data also suggest an association between the presence of the C/T genotype at the IRAK1 (g.6435C4T) locus and decreased G-ve infections. Further, the TLR5 (Arg392X) variant was associated with a higher WBC count among infants who developed C þ ve infections. The use of a genetically heterogeneous population, examination of a limited number of TLR pathway variants and lack of a replication cohort are limitations of this study. 
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Studies by Agnese et al. 21 and Lorenz et al. 20 showed that TLR4 SNPs are associated with increased G-ve sepsis and shock in adult intensive care patients. We noted similar conclusions in VLBW infants. However, our results differ from Abu-Maziad et al. 22 who did not find an association between the TLR4 variant (rs4986791) and infections in a retrospective case-control study done in premature infants. In their study, control infants were not entirely VLBW infants and there were three times as many males among cases; gender composition was more balanced among controls. Ahrens et al. 23 did not demonstrate an association between the TLR4 (rs4986790) variant and sepsis in VLBW infants. In our study, TLR4 variants were more robustly associated with G-ve infections rather than C þ ve infections; an association not investigated by this group. Szebeni et al. 24 noted no association between TLR4 variants and NEC in VLBW infants but did not examine relationships between TLR4 SNPs and sepsis. The study populations were predominantly Caucasian in the above studies while 30% of the infants in our cohort were African American. However, the association between TLR4 variants and G-ve infections was robust among Caucasian infants in our cohort, and remained significant after correcting for other confounders. As TLR function is critical for immune responses in the lung, urinary tract and blood our initial analysis included tracheal infections along with blood stream and urinary tract infections. In this study, ventilator-associated lung infection was defined using clinical criteria that included pulmonary radiographic changes and a change in the clinical status. These criteria do not clearly distinguish lung infections from tracheal colonization and is a limitation of this study. In analysis that excluded infants with tracheal infections, TLR4 SNPs were still associated with G-ve infection.
TLR4 recognizes LPS, a cell-membrane component of G-ve bacteria such as Klebsiella pneumoniae and Escherichia coli. 10 The variants examined in this study alter the LPS recognition domain of TLR4, which would result in aberrant pathogen recognition and sepsis susceptibility. 10, 25 Rallabhandi et al. 18 have demonstrated that both TLR4 variants examined in this study decrease LPS-mediated cytokine responses in monocytes and that the presence of both variants compromises TLR4 function more than either variant. In our cohort, presence of both variants was more robustly associated with C þ ve and G-ve infections compared with presence of the TLR4 SNP (rs4986790) alone. Further, Arbour et al. 26 and Tulic et al. 27 have demonstrated that adults and children who are heterozygous for these TLR4 SNPs have impaired responses to endotoxin and LPS respectively, supporting impaired function with haploinsufficiency. Identification of genetic markers associated with higher risk of G-ve infections in VLBW infants is important as mortality associated with G-ve sepsis is 425%.
1,3
All-cause neonatal mortality and sepsis-related mortality are higher in male VLBW infants. 3, 28 The IRAK1 variant (rs1059703) was shown to be associated with increased C-reactive protein in females from the Diabetes Heart Study suggesting a genderdependent effect. 19 In our cohort, there were less G-ve infections among females of Caucasian descent and female infants with the T/C genotype at the IRAK1 locus (g.6435T4C) appeared to be protected against G-ve infections. In a study examining associations between this variant and sepsis in adults, Arcaroli et al. 29 reported that patients who were homozygous for the IRAK1 variant had increased sepsis-related mortality. We did not find increased infections in VLBW infants homozygous for this variant. Premature infants differ from adults in having dysregulated TLRmediated responses to bacteria and this may explain differences in sepsis outcomes. 8, 30 The effect of the heterozygous state on immune responses against G-ve bacteria as well as replication of our findings remains topics for future research. In contrast to adult studies and a study in preterm infants o37 weeks, we did not find an association between the TLR2 (rs5743708) variant and G þ ve infections. 22, 31 A potential explanation could be that TLR2 SNPs are a marker of premature birth rather than infection. In analysis that corrected for gestational age, the association between TLR2 SNPs and G þ ve infections were no longer evident. 22 Neutrophils are a critical component of the immune system and have a key role in the acute-phase response to infection. 15, 16, 32 Infants with the TLR5 variant had increased WBC/ANC counts during episodes of bacterial infections and birth weight was associated with higher WBC count in infants with the TLR5 variant. As far as we are aware, this is the first study to examine associations between functional TLR variants and WBC counts during infections. Previously, Arbour et al. 26 reported that adults with TLR4 SNPs showed decreased bronchial responsiveness to inhaled endotoxin. Michel et al. 33 demonstrated that adults with the TLR4 (rs4986790 or rs4986791) variants had decreased CRP levels after systemic challenge with LPS. We speculate that loss of TLR5 function arising from the TLR5 variant may exaggerate immune responses through other TLRs and alter WBC counts. It is possible that our results could be different if we had a larger cohort, and as such our results should be considered preliminary. Whether TLR SNPs alter in vivo cellular and cytokine responses during sepsis is an area for future research.
Data from this and other studies support our hypothesis that functional TLR signaling pathway SNPs will be penetrant in VLBW infants and contribute to morbidity from pathogenmediated diseases. 6, 22 Further research is needed to validate the findings of this study, identify other genetic markers in immune genes that alter sepsis susceptibility, and to understand mechanisms by which variants contribute to disease pathogenesis. Characterization of robust genetic biomarkers that can predict susceptibility/severity of infections in this population will represent a major advance in this field and aid the development of immune-based prevention and treatment strategies to decrease the burden of microbial disease in this population.
